Hosted on MSN1mon
Cowen initiates Palvella Therapeutics with buy, $44 targetThe study, published in the Journal of Vascular Anomalies ... particularly for cutaneous venous malformations (VMs). The firm believes that the VM market represents a larger opportunity ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback